Once- versus twice-daily everolimus for the prevention of rejection in liver transplant recipients also taking tacrolimus

Trial Profile

Once- versus twice-daily everolimus for the prevention of rejection in liver transplant recipients also taking tacrolimus

Completed
Phase of Trial: Phase II

Latest Information Update: 06 May 2015

At a glance

  • Drugs Everolimus (Primary) ; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
    • 22 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top